Pandemic darlings had a lot in common with AI, quantum computing and 3-D printing.

Ionis Pharmaceuticals (NASDAQ:IONS) underwent analysis by 7 analysts in the last quarter, revealing a spectrum of viewpoints from bullish to bearish. The table below provides a snapshot of their ...

TAMPA, Fla. — New York Yankees ace Gerrit Cole will have season-ending Tommy John surgery on his right elbow on Tuesday. The Yankees said the 34-year-old right-hander was examined Monday by Dr ...

For the pharmaceutical company ... More than 56,000 of J&J's 138,000 workers have taken a generative AI training course, which is required before any employee is authorized to use the technology.

LOS ANGELES--(BUSINESS WIRE)--The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc. (“Regeneron ...

He expressed reservations about buying shares of Recursion Pharmaceuticals in light of ... He added, "We're going to have to hold off. I gotta meet them face to face and see what's going on." ...

New Jersey's pharmaceutical industry supports 370,000 ... patients in hospitals where we have no other solutions," he said. "So we absolutely want to make sure that this work moves forward." ...

LOS ANGELES, March 10, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals, Inc.

In the last 5 years Fennec Pharmaceuticals saw its revenue grow at 90% per year. That's well above most pre-profit companies. While long-term shareholders have made money, the 7% per year gain over ...

Cumberland Pharmaceuticals Inc.’s trailing earnings per share are negative, so the stock does not have a meaningful P/E ratio. We suggest investors evaluate other financial metrics to understand its ...

Seth Moulton — to speak more frankly. Still, few Democrats are comfortable going where Newsom and Moulton have — to clearly state that trans athletes shouldn’t be allowed in women’s sports.

LOS ANGELES, March 7, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Regeneron Pharmaceuticals ...